busulfan and Acquired Immune Deficiency Syndrome studies

busulfan and Acquired Immune Deficiency Syndrome

Research Excerpts

Excerpt	Relevance	Reference
"A 25-year-old woman with AIDS was submitted to HLA-identical allogeneic BMT after cytoablation with busulphan and cyclophosphamide and combined anti-HIV-1 therapy with zidovudine, IFN-alpha 2 and anti-HIV-1-specific T cell clones."	1.29	Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. ( Arras, M; Boero, R; Carcassi, C; Contu, L; La Nasa, G; Ledda, A; Orrù, S; Pintus, A; Pizzati, A; Vacca, A, 1993)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (50.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Spitzer, TR	1
Ambinder, RF	1
Lee, JY	1
Kaplan, LD	1
Wachsman, W	1
Straus, DJ	1
Aboulafia, DM	1
Scadden, DT	1
Contu, L	1
La Nasa, G	1
Arras, M	1
Pizzati, A	1
Vacca, A	1
Carcassi, C	1
Ledda, A	1
Boero, R	1
Orrù, S	1
Pintus, A	1

Studies

Spitzer, TR

Ambinder, RF

Lee, JY

Kaplan, LD

Wachsman, W

Straus, DJ

Aboulafia, DM

Scadden, DT

Contu, L

La Nasa, G

Arras, M

Pizzati, A

Vacca, A

Carcassi, C

Ledda, A

Boero, R

Orrù, S

Pintus, A

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma[NCT00005824]	Phase 2	0 participants	Interventional	2000-11-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma[NCT00005824]

Phase 2

0 participants

Interventional

2000-11-30

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for busulfan and Acquired Immune Deficiency Syndrome

Article	Year
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan;	2008

Article

Year

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:1

Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan;

2008

Other Studies

1 other study available for busulfan and Acquired Immune Deficiency Syndrome

Article	Year
Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone marrow transplantation, 1993, Volume: 12, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulf	1993

Article

Year

Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS.

Bone marrow transplantation, 1993, Volume: 12, Issue:6

Topics: Acquired Immunodeficiency Syndrome; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulf

1993